A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains

BACKGROUND: Daptomycin is an important drug used in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection. A high dose of daptomycin is indicated for an MRSA infection with a minimum inhibitory concentration (MIC) of 1 mg/L for daptomycin. Combination therapies with daptomyci...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yi-Chien, Chen, Pao-Yu, Wang, Jann-Tay, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503441/
https://www.ncbi.nlm.nih.gov/pubmed/31060599
http://dx.doi.org/10.1186/s40360-019-0305-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503441/
https://www.ncbi.nlm.nih.gov/pubmed/31060599
http://dx.doi.org/10.1186/s40360-019-0305-y

Ejemplares similares